Presentation at the 38th Annual Conference of the Japanese Society for Alternatives to Animal Experiments
At the “38th Annual Conference of the Japanese Society for Alternatives to Animal Experiments,” held from November 1 (Saturday) to 3 (Monday), 2025, our CEO Ozawa presented at a symposium.
Cell Manufacturing with AI and Robotics
— Toward Achieving Highly Reliable Processes in Regenerative Medicine —
Industry leaders explained cutting-edge technologies and case studies for efficiently solving complex condition searches in life science experiments using AI. From over 60 cases ranging from pharmaceutical development to AI integration with analytical instruments, notable achievements such as culture condition optimization using robotics were selected and presented.
Date: November 3, 2025 (Monday) 9:00-10:50
Session: Symposium 16 From Kanagawa: Public Support Functions for the Industrialization of Regenerative and Cell Therapy as a Core Industry!
Presentation title:
Cell Manufacturing with AI and Robotics
— Toward Achieving Highly Reliable Processes in Regenerative Medicine —
Speaker: Yosuke Ozawa, CEO, Epistra Inc.
Venue: Pacifico Yokohama North, Venue 4 (G418, G419) Details here
Related Articles
Epistra Contributes Article on "AI-Robot-Driven Drug Development" to Pharmacia, Journal of the Pharmaceutical Society of Japan
Epistra CTO Taku Tsuzuki and CEO Yosuke Ozawa contributed an article on AI-robot-driven drug development to Pharmacia, Vol. 62 No. 7, published by the Pharmaceutical Society of Japan.
Cell Culture Optimization Software 'CellTune Ver.2' Launches Globally
Epistra Inc. announces the global launch of 'CellTune Ver.2,' the updated version of the co-developed cell culture optimization software with Shimadzu Corporation, on June 29, 2026. The new version introduces cloud-based subscription delivery and overseas expansion of custom media manufacturing services.
Speaking Engagement: CEO Yosuke Ozawa Presented at the 10th Shonan iPark Regenerative Medicine Seminar
On June 3, 2026, Epistra Inc. CEO Yosuke Ozawa presented at the 10th Shonan iPark Regenerative Medicine Seminar, sharing implementation case studies and future prospects for AI and mathematical optimization in regenerative medicine process development.